BOSTON – Sept. 9, 2022 – David J. Dykeman, co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group, and co-managing shareholder of the firm’s Boston office has been named “Patent Strategy Attorney of the Year – Massachusetts” by LMG Life Sciences. Winners were announced at an awards dinner in New York City on Sept. 8.
Additionally, Lori G. Cohen, who is vice chair of Greenberg Traurig and co-chair of the firm’s Global Litigation Practice and its Trial Practice, was shortlisted for the LMG Life Sciences Product Liability Attorney of the Year award.
“The life sciences industry has always been an important part of Greenberg Traurig’s global practice, and this recognition highlights the firm’s strong commitment to our innovative clients,” said Richard A. Rosenbaum, Greenberg Traurig’s Executive Chairman.
“Massachusetts is one of the thriving hubs for life sciences and medical technology companies, and Dave Dykeman is a go-to patent attorney for innovators in that region and across the country and globe,” said Wayne H. Elowe, co-chair of the firm’s global Life Sciences & Medical Technology Group.
LMG Life Sciences is considered the definitive guide to leading U.S., Canada, Europe, Middle East, and Africa law firms and lawyers specializing in the life sciences industry. The guide’s LMG Life Sciences Awards recognize key law firms, lawyers, and the innovative work accomplished throughout the life sciences industry. They are based on marketplace and client feedback, as well as information provided by firms, which can only be ranked if the market deems them worthy of consideration.
A registered patent attorney with 25 years of experience in patent and intellectual property law, Dykeman has been listed as an LMG Life Sciences Star since 2014. His practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. Dykeman provides strategic patent portfolio development and intellectual property advice for clients, including major research institutions, multinational corporations, and early stage companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities. An author of over 55 articles and a speaker at over 50 conferences on intellectual property law, Dykeman is the founding co-chair of the American Bar Association’s Medical Devices Committee.